Zobrazeno 1 - 10
of 23
pro vyhledávání: '"Egil S Blix"'
Autor:
Dagny Førde, Thomas Kilvær, Mona Irene Pedersen, Egil S Blix, Ilona Urbarova, Erna-Elise Paulsen, Mehrdad Rakaee, Lill-Tove Rasmussen Busund, Tom Donnem, Sigve Andersen
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionTumor-infiltrating lymphocytes are both prognostic and predictive biomarkers for immunotherapy response. However, less is known about the survival benefits oftheir subpopulations.MethodsUsing machine learning models, we assessed the clini
Externí odkaz:
https://doaj.org/article/757f0a38143c48e79d7e199fbd984086
Autor:
Oleksii Nikolaienko, Hans P. Eikesdal, Elisabet Ognedal, Bjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, Emiel A. M. Janssen, Synnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, Stian Knappskog, Per E. Lønning
Publikováno v:
Genome Medicine, Vol 15, Iss 1, Pp 1-15 (2023)
Abstract Background Normal cell BRCA1 epimutations have been associated with increased risk of triple-negative breast cancer (TNBC). However, the fraction of TNBCs that may have BRCA1 epimutations as their underlying cause is unknown. Neither are the
Externí odkaz:
https://doaj.org/article/0089602380aa46b390f13cb9bbdb281f
Autor:
Ahmed R. Eldesoky, Giulio Francolini, Mette S. Thomsen, Esben S. Yates, Tine B. Nyeng, Carine Kirkove, Claus Kamby, Egil S. Blix, Mette H. Nielsen, Zahra Taheri-Kadkhoda, Martin Berg, Birgitte V. Offersen
Publikováno v:
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 36-40 (2017)
The effect of Atlas-based automated segmentation (ABAS) on dose volume histogram (DVH) parameters compared to manual segmentation (MS) in loco-regional radiotherapy (RT) of early breast cancer was investigated in patients included in the Skagen Trial
Externí odkaz:
https://doaj.org/article/fbec48d72b1e4bf78fa6be387266cc22
Autor:
Oleksii Nikolaienko, Hans P. Eikesdal, Bjørnar Gilje, Steinar Lundgren, Egil S. Blix, Helge Espelid, Jürgen Geisler, Stephanie Geisler, Emiel A.M. Janssen, Synnøve Yndestad, Laura Minsaas, Beryl Leirvaag, Reidun Lillestøl, Stian Knappskog, Per E. Lønning
BackgroundNormal cellBRCA1epimutations have been associated with increased risk of triple-negative breast cancer (TNBC). However, the fraction of TNBCs that may haveBRCA1epimutations as their underlying cause is unknown.MethodsTo address this questio
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d2190358b63fbbf66a48d7d6bfcc2496
https://doi.org/10.1101/2023.05.14.23289949
https://doi.org/10.1101/2023.05.14.23289949
Autor:
Kjetil, Taskén, Hege E G, Russnes, Eline, Aas, Line, Bjørge, Egil S, Blix, Espen, Enerly, Gro L, Fagereng, Åsmund, Flobak, Bjørnar, Gilje, Bjørn T, Gjertsen, Tormod K, Guren, Jutta, Heix, Eivind, Hovig, Randi, Hovland, Per E, Lønning, Leonardo A, Meza-Zepeda, Per M, Mæhle, Hilde L, Nilsen, Steinar Ø, Thoresen, Ketil, Widerberg, Sigbjørn, Smeland, Sissel F, Wahl
Publikováno v:
Nature medicine. 28(5)
Autor:
Helge Espelid, Stian Knappskog, Alba Llop-Guevara, Judith Balmaña, Beryl Leirvaag, Jürgen Geisler, Bjørnar Gilje, Laura Minsaas, Asmaa Elzawahry, Steinar Lundgren, Olav Karsten Vintermyr, Egil S. Blix, Per Eystein Lønning, Synnøve Yndestad, Geirfinn Vagstad, Emiel A. M. Janssen, Hildegunn Siv Aase, Andreas Venizelos, Hans Petter Eikesdal, Violeta Serra, Einar Gudlaugsson, Turid Aas
Publikováno v:
Annals of Oncology
Background The antitumor efficacy of PARP inhibitors (PARPi) for breast cancer patients harboring germline BRCA1/2 (gBRCA1/2) mutations is well established. While PARPi monotherapy was ineffective in patients with metastatic triple negative breast ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::71c4233c7a23662c06d637156987fe9c
https://hdl.handle.net/10037/20445
https://hdl.handle.net/10037/20445
Autor:
Steinar Hustad, Marit Synnestvedt, Jan Terje Kvaløy, Daniel L. Hertz, Anna Barbro Sætersdal, Gunnar Mellgren, Bjørnar Gilje, Elin Borgen, Ingvil Mjaaland, Håvard Søiland, Egil S. Blix, Emiel A. M. Janssen, Tone Hoel Lende, Kjetil Weyde, Gro Wiedswang, Bjørn Naume, Ersilia Bifulco, Thomas Helland
Publikováno v:
Molecular Oncology
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Molecular Oncology, Vol 15, Iss 4, Pp 957-967 (2021)
Concentrations of active tamoxifen metabolites may be predictive of tamoxifen efficacy, and several therapeutic thresholds have been reported. This study of 406 ER+ breast cancer patients replicated an association between a previously reported active
Autor:
Gunnar Mellgren, Emiel A. M. Janssen, Bjørnar Gilje, Håvard Søiland, Tone Hoel Lende, Egil S. Blix, Daniel L. Hertz, Marit Synnestvedt, Kjetil Weyde, Anna Barbro Sætersdal, Jan Terje Kvaløy, Gro Wiedswang, Ersilia Bifulco, Bjørn Naume, Thomas Helland, Ingvil Mjaaland, Elin Borgen, Steinar Hustad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::21f0711788396638577e84e0563a432e
https://doi.org/10.1002/1878-0261.12865/v2/response1
https://doi.org/10.1002/1878-0261.12865/v2/response1
Autor:
M.H. Nielsen, Carine Kirkove, Birgitte Vrou Offersen, Giulio Francolini, Zahra Taheri-Kadkhoda, T.B. Nyeng, M.S. Thomsen, Ahmed R Eldesoky, Egil S. Blix, Martin Berg, E.S. Yates, Claus Kamby
Publikováno v:
Clinical and Translational Radiation Oncology
Eldesoky, A R, Francolini, G, Thomsen, M S, Yates, E S, Nyeng, T B, Kirkove, C, Kamby, C, Blix, E S, Nielsen, M H, Taheri-Kadkhoda, Z, Berg, M & Offersen, B V 2017, ' Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1 : A multi-institutional study ', Clinical and Translational Radiation Oncology, vol. 2, pp. 36-40 . https://doi.org/10.1016/j.ctro.2017.01.004
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 36-40 (2017)
Ibrahim, A R M E, Francolini, G, Thomsen, M S, Yates, E S, Nyeng, T B, Kirkove, C, Kamby, C, Blix, E S, Nielsen, M H, Taheri-Kadkhoda, Z, Berg, M & Offersen, B V 2017, ' Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study ', Clinical and Translational Radiation Oncology, vol. 2, pp. 36-40 . https://doi.org/10.1016/j.ctro.2017.01.004
Eldesoky, A R, Francolini, G, Thomsen, M S, Yates, E S, Nyeng, T B, Kirkove, C, Kamby, C, Blix, E S, Nielsen, M H, Taheri-Kadkhoda, Z, Berg, M & Offersen, B V 2017, ' Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1 : A multi-institutional study ', Clinical and Translational Radiation Oncology, vol. 2, pp. 36-40 . https://doi.org/10.1016/j.ctro.2017.01.004
Clinical and Translational Radiation Oncology, Vol 2, Iss C, Pp 36-40 (2017)
Ibrahim, A R M E, Francolini, G, Thomsen, M S, Yates, E S, Nyeng, T B, Kirkove, C, Kamby, C, Blix, E S, Nielsen, M H, Taheri-Kadkhoda, Z, Berg, M & Offersen, B V 2017, ' Dosimetric assessment of an Atlas based automated segmentation for loco-regional radiation therapy of early breast cancer in the Skagen Trial 1: A multi-institutional study ', Clinical and Translational Radiation Oncology, vol. 2, pp. 36-40 . https://doi.org/10.1016/j.ctro.2017.01.004
Highlights • 40 dose plans from the Skagen Trial 1 collected from Denmark, Belgium and Norway. • Atlas-based automated segmentation of each CT scan was obtained using MIM Maestro™. • DSC and difference in volume with manual segmentation were
Autor:
Hans Petter Eikesdal, Marianne Ewertz, Sajitha Rajendiran, Lars Ottestad, Line Fronth, Liv Hege Aksnes, Egil S. Blix
Publikováno v:
Ottestad, L, Fronth, L, Rajendiran, S, Hege Aksnes, L, Eikesdal, H P, Støre Blix, E & Ewertz, M 2019, ' Observational study of everolimus plus exemestane in postmenopausal women with hormone receptor-positive, HER2-negative advanced breast cancer ', Acta Oncologica, vol. 58, no. 3, pp. 385-387 . https://doi.org/10.1080/0284186X.2019.1566771
To the editor,Aberrant signaling through the phosphatidylinositol 3-kinase (PI3K)-Akt-mammalian target of rapamycin (mTOR) pathway is a well-known mechanism of resistance to endocrine therapy in pa...